{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:37:08Z","timestamp":1777631828654,"version":"3.51.4"},"reference-count":29,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/or.2016.5198","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T05:29:53Z","timestamp":1477286993000},"page":"3588-3596","source":"Crossref","is-referenced-by-count":14,"title":["Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling"],"prefix":"10.3892","volume":"36","author":[{"given":"Jun","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"key20180107221920_b1-or-36-06-3588","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180107221920_b2-or-36-06-3588","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2174\/138920111798377076","article-title":"Metastasis: Recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin","volume":"12","author":"Alonso","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"key20180107221920_b3-or-36-06-3588","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"key20180107221920_b4-or-36-06-3588","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s13277-012-0417-0","article-title":"MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells","volume":"33","author":"Wu","year":"2012","journal-title":"Tumour Biol"},{"key":"key20180107221920_b5-or-36-06-3588","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.modgep.2006.03.008","article-title":"Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1)","volume":"6","author":"Durmus","year":"2006","journal-title":"Gene Expr Patterns"},{"key":"key20180107221920_b6-or-36-06-3588","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-06-0030","article-title":"Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers","volume":"12","author":"Tang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107221920_b7-or-36-06-3588","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1349-7006.2012.02292.x","article-title":"CTHRC1 is upregulated by promoter demethylation and transforming growth factor-\u03b21 and may be associated with metastasis in human gastric cancer","volume":"103","author":"Wang","year":"2012","journal-title":"Cancer Sci"},{"key":"key20180107221920_b8-or-36-06-3588","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.18632\/oncotarget.2421","article-title":"Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer","volume":"5","author":"Ke","year":"2014","journal-title":"Oncotarget"},{"key":"key20180107221920_b9-or-36-06-3588","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3013","article-title":"Suppression of ovarian cancer cell tumorigenicity and evasion of cisplatin resistance using a truncated epidermal growth factor receptor in a rat model","volume":"65","author":"Chan","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107221920_b10-or-36-06-3588","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ygyno.2008.02.030","article-title":"Implications of EGFR inhibition in ovarian cancer cell proliferation","volume":"109","author":"Phelps","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180107221920_b11-or-36-06-3588","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107221920_b12-or-36-06-3588","first-page":"247","article-title":"EGF\/ErbB receptor family in ovarian cancer","volume":"107","author":"Maihle","year":"2002","journal-title":"Cancer Treat Res"},{"key":"key20180107221920_b13-or-36-06-3588","first-page":"269","article-title":"Inhibition of EGFR\/PI3K\/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells","volume":"29","author":"Zhou","year":"2006","journal-title":"Int J Oncol"},{"key":"key20180107221920_b14-or-36-06-3588","doi-asserted-by":"crossref","first-page":"e43577","DOI":"10.1371\/journal.pone.0043577","article-title":"Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model","volume":"7","author":"Loganathan","year":"2012","journal-title":"PLoS One"},{"key":"key20180107221920_b15-or-36-06-3588","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/onc.2010.240","article-title":"Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells","volume":"29","author":"Gan","year":"2010","journal-title":"Oncogene"},{"key":"key20180107221920_b16-or-36-06-3588","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/mnfr.201000292","article-title":"Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK\/Akt, PKC\/Raf\/ERK, p38 MAPK, and AP-1 signaling","volume":"55","author":"Hwang","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"key20180107221920_b17-or-36-06-3588","doi-asserted-by":"crossref","first-page":"35813","DOI":"10.18632\/oncotarget.5358","article-title":"High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis","volume":"6","author":"Hou","year":"2015","journal-title":"Oncotarget"},{"key":"key20180107221920_b18-or-36-06-3588","doi-asserted-by":"crossref","first-page":"e96718","DOI":"10.1371\/journal.pone.0096718","article-title":"MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT\/ERK1\/2 inactivation by targeting EGFR in epithelial ovarian cancer","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"key20180107221920_b19-or-36-06-3588","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2008.02.062","article-title":"Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs","volume":"266","author":"Cao","year":"2008","journal-title":"Cancer Lett"},{"key":"key20180107221920_b20-or-36-06-3588","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2009.10.085","article-title":"The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer","volume":"116","author":"Khalil","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107221920_b21-or-36-06-3588","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jclinpath-2011-200106","article-title":"Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: An immunohistochemical study","volume":"64","author":"Kharaishvili","year":"2011","journal-title":"J Clin Pathol"},{"key":"key20180107221920_b22-or-36-06-3588","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neo.2014.03.001","article-title":"CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt\/PCP-Rho signaling","volume":"16","author":"Ma","year":"2014","journal-title":"Neoplasia"},{"key":"key20180107221920_b23-or-36-06-3588","doi-asserted-by":"crossref","first-page":"519","DOI":"10.18632\/oncotarget.1714","article-title":"Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells","volume":"5","author":"Kim","year":"2014","journal-title":"Oncotarget"},{"key":"key20180107221920_b24-or-36-06-3588","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/carcin\/bgs378","article-title":"Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells","volume":"34","author":"Park","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180107221920_b25-or-36-06-3588","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20180107221920_b26-or-36-06-3588","doi-asserted-by":"crossref","first-page":"e39520","DOI":"10.1371\/journal.pone.0039520","article-title":"Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"key":"key20180107221920_b27-or-36-06-3588","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10620-012-2036-4","article-title":"Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells","volume":"57","author":"Chang","year":"2012","journal-title":"Dig Dis Sci"},{"key":"key20180107221920_b28-or-36-06-3588","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/1471-2407-12-462","article-title":"PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse","volume":"12","author":"Konishi","year":"2012","journal-title":"BMC Cancer"},{"key":"key20180107221920_b29-or-36-06-3588","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1158\/1078-0432.CCR-11-0408","article-title":"hVps37A status affects prognosis and cetuximab sensitivity in ovarian cancer","volume":"17","author":"Wittinger","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.5198\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T19:35:20Z","timestamp":1568489720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.5198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,10,24]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/or.2016.5198"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.5198","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}